March 20, 2020
Funding for Coronavirus 2019 Treatments, Diagnostics, and Related Solutions
Congress and US federal agencies have responded to the coronavirus threat with funding aimed at fast-tracking promising technologies and products that can help address the needs. Examples of recently funded projects include support of the first high-throughput COVID-19 diagnostic test from Hologic as well as tests from several other companies.
Medical Countermeasures BARDA Portal
BARDA has provided a single point of entry to government agencies that are looking for products and technologies to address the COVID-19 outbreak. Open to independent entities or teams from academic institutions, government labs and private sector organizations.
Required submission materials include a description of your product or technology, a slide deck, manuscript, publications, or other non-confidential information.
Agencies are looking for vaccines, diagnostics, therapeutics, and other products and services.
Broad Agency Announcement
Additional information about the program
BARDA and the Public Health Emergency
COVID-19 Research Supplements to Current NIH Grants and Cooperative Agreements
The National Heart, Lung, and Blood Institute (NHLBI) has issued a Notice of Special Interest in response to the urgent need for research on the Coronavirus 2019 and the biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Research interests include, but not limited to, host factors, manifestations, complications, time course of virus-host interactions, biological pathways, use of artificial intelligence to understand the COVID-19 pathways and comorbidities, antibody response, development of GMP quality hyperimmune globulin from patients who have recovered, and testing strategies.